These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 16546843)
21. Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Zhao R; Ma X; Xie X; Shen GX Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E104-11. PubMed ID: 19401454 [TBL] [Abstract][Full Text] [Related]
22. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709 [TBL] [Abstract][Full Text] [Related]
23. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804 [TBL] [Abstract][Full Text] [Related]
25. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway. Otto A; Fontaine J; Berkenboom G J Cardiovasc Pharmacol; 2006 Jul; 48(1):842-9. PubMed ID: 16891913 [TBL] [Abstract][Full Text] [Related]
26. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. Alvarez Y; Pérez-Girón JV; Hernanz R; Briones AM; García-Redondo A; Beltrán A; Alonso MJ; Salaices M J Pharmacol Exp Ther; 2007 Apr; 321(1):381-8. PubMed ID: 17244722 [TBL] [Abstract][Full Text] [Related]
27. Effects of red grape juice polyphenols in NADPH oxidase subunit expression in human neutrophils and mononuclear blood cells. Dávalos A; de la Peña G; Sánchez-Martín CC; Teresa Guerra M; Bartolomé B; Lasunción MA Br J Nutr; 2009 Oct; 102(8):1125-35. PubMed ID: 19450372 [TBL] [Abstract][Full Text] [Related]
28. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy. Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559 [TBL] [Abstract][Full Text] [Related]
29. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Yao EH; Fukuda N; Matsumoto T; Kobayashi N; Katakawa M; Yamamoto C; Tsunemi A; Suzuki R; Ueno T; Matsumoto K Hypertens Res; 2007 Nov; 30(11):1119-28. PubMed ID: 18250561 [TBL] [Abstract][Full Text] [Related]
30. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways. Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797 [TBL] [Abstract][Full Text] [Related]
31. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats. Yamamoto M; Suzuki A; Jokura H; Yamamoto N; Hase T Nutrition; 2008 May; 24(5):470-6. PubMed ID: 18329851 [TBL] [Abstract][Full Text] [Related]
32. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome. Wei JL; Cui HM; Ma CY Eur J Med Res; 2007 May; 12(5):216-21. PubMed ID: 17513194 [TBL] [Abstract][Full Text] [Related]
33. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083 [TBL] [Abstract][Full Text] [Related]
34. The role of the alpha-1 adrenoceptor in modulating human mesangial cell matrix production. Pawluczyk IZ; Patel SR; Harris KP Nephrol Dial Transplant; 2006 Sep; 21(9):2417-24. PubMed ID: 16705025 [TBL] [Abstract][Full Text] [Related]
35. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354 [TBL] [Abstract][Full Text] [Related]
36. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Ceral J; Solar M Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415 [TBL] [Abstract][Full Text] [Related]
37. Effects of eprosartan on mitochondrial membrane potential and H2O2 levels in leucocytes in hypertension. Labiós M; Martínez M; Gabriel F; Guiral V; Ruiz-Aja S; Beltrán B; Muñoz A J Hum Hypertens; 2008 Jul; 22(7):493-500. PubMed ID: 18385744 [TBL] [Abstract][Full Text] [Related]
39. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related]